fda warning bpc-157 safety cancer panel backs compounded BPC-157, KPV peptides in win for RFK Jr FDA may take an important

FDA may take an important step toward opening the peptide floodgates this week This Week at FDA: HHS proposes drug acceleration initiatives, FDA warns companies about falsifying test data, and more RAPS An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR

SKU: 31839792038 · From webdevsolutions.tech